For Investors
Independent technical diligence on agricultural biologicals
Agricultural biologicals are technically complex. A product can be well documented and still fail under field conditions.
Quadros Bio Inc. provides independent, science-based risk intelligence for capital deployment in agricultural biologicals.
17+
years of academic, lab, and field experience across three continents
14
crop systems across five countries in which strains have been trialled
7
readiness layers in the QBIView assessment framework
How We Help
Where evidence gaps appear
The gap between a promising bacterial strain and a product that performs in farmers' fields is where biologicals investments lose value.
01
Pre-Investment
Technical Validation
QBIView™ Technology Assessment
QBIView™ is Quadros Bio Inc.'s due diligence framework: a structured, evidence-based assessment of a biological product or company across seven readiness layers.
Every assessment applies our 7 Readiness Layers framework. Each layer is scored independently, so weaknesses do not hide behind strengths.
The 7 Readiness Layers
- 01Biological Validity
- 02Product Integrity
- 03Field Translation
- 04Regulatory Pathway
- 05Commercial Viability
- 06Organizational & IP Strength
- 07R&D and Governance
Deliverables include:
- →Structured technical interview with founders and technical team
- →Independent patent landscape search across CIPO, USPTO, EPO, INPI, and WIPO
- →Regulatory pathway assessment with realistic timelines
- →Competitive benchmarking against products in similar categories
- →Three commercial scenarios, each with the assumptions it depends on
- →Final QBI Verdict: Go / Conditional / No-Go
- →Specific deal-term restructuring recommendations
The report closes with a QBI Verdict (Go / Conditional / No-Go) and specific deal-term restructuring recommendations, naming both the risks and the structures that address them.
02
Ongoing Portfolio
Intelligence
QBI Partnership Retainer
Regulatory decisions, emerging strain data, competitive approvals, and field trial failures reshape the landscape continuously, and most of it does not appear in pitch decks or press releases.
The retainer reports the science affecting positions already held: regulatory decisions, competitive approvals, IP filings, and published field results.
What we monitor
- →Regulatory monitoring at PMRA, CFIA, and EPA
- →Competitive product approvals and IP filing tracking
- →Early detection of evidence gaps, regulatory changes, field results, IP events, and changes in technical risk
For funds holding multiple biologicals positions, the retainer supplies scientific review.
03
Brazilian Research
Network
Deal Origination
Its regulatory framework, field trial infrastructure, and research output, anchored by Embrapa and leading federal universities, is producing innovations that most North American investors encounter only after valuations have already climbed.
Quadros Bio Inc. holds direct research relationships with the Embrapa network and Brazilian academic institutions built over 17+ years of primary field research across South American soil systems. We surface technologies at the stage where scientific validation is possible, and we assess them using the same QBIView™ framework before you take a meeting.
Confidential by default. Not sold. Not published. Not shared without permission.
Request a deal review
Put a deal through QBIView.
Tell us about the deal you are evaluating. We respond within two business days with a scoping note and a quote.